Phospholipases A2 (PLA,, EC 3.1.1.4) represent a growing superfamily of enzymes that catalyse the hydrolysis of glycerophospholipids at the sn-2 position, to produce free fatty acids and 1-acyl lysophospholipids [ 1,2,3]. The major polyunsaturated fatty acid generated upon PLA2 activation is arachidonic acid which is the rate-limiting precursor of eicosanoid formation. The lysoglycerophospholipid either acts as a substrate for lysophospholipase or is rapidly converted to platelet activating factor (PAF) by acetyltransferase. Arachidonic acid, eicosanoids and PAF act as intracellular second messengers and participate in a variety of regulatory and inflammatory responses.
Ethanolamine plasmalogens constitute a unique class of glycerophospholipids with a vinyl ether linkage at the sn-1 position of the glycerol backbone and are a major phospholipid constituent of human neural membranes. In comparison to diacylglycerophospholipids, plasmalogens have unique membrane biophysical characteristics, have a propensity to facilitate membrane fusion and are selectively hydrolysed during ischaemic and traumatic brain injuries [4, 5] . Recent studies using tissue obtained post-mortem have indicated that plasmalogens are decreased in different regions of the brain from Alzheimer's disease (AD) patients when compared with agematched controls [6, 7] . This decrease in plasmalogens in AD is accompanied by a marked elevation in glycerophosphoethanolamine and Abbreviations used: PLA2, phospholipase(s) A,; AD, Alzheimer's disease; ROS, reactive oxygen species; PAF, platelet activating factor; HD, Huntington's disease; PD, Parkinson's disease. 'To whom correspondence should be addressed.
phosphoethanolamine [8] . These metabolites have been shown to augment the aggregation of P-amyloid [9] , a peptide that accumulates in AD brain and may be responsible for the stimulation of various phospholipases [ 101.
The purpose of the present communication is to describe the enzymic properties and role of plasmalogen-selective PLA2 in brain tissue and to discuss its involvement in AD.
Properties of plasmalogen-selective pLA2
We have purified and characterized a plasmalogen-selective PLAz from bovine brain [4, 11] . The purified enzyme shows optimal activity at pH 8.0 and has K,,, and V , , , values of 70 pM and 7.0 nmol/min per mg protein, respectively. The purified enzyme preparation hydrolyses phosphatidylethanolamine with a specific activity of 0.188 nmol/min per mg protein. Thus, the activity of this PLA2 towards ethanolamine plasmalogen is 30 times higher than towards phosphatidylethanolamine. This PLA2 does not require Ca2+, has a molecular mass of 39 kDa, and is localized in the cytosol. The purified enzyme is inhibited by ATP and ADP in a concentration-dependent manner. Non-ionic detergents, Triton X-100 and Tween-20, stimulate the enzymic activity. Other detergents, such as sodium deoxycholate, taurocholate and octyl glucoside, inhibit this enzyme. SH-group blocking agents, iodoacetate and N-ethylmaleimide, inhibit plasmalogen-selective PLA,. Quinacrine and nordihydroguaiaretic acid inhibit the plasmalogen-selective PLA2 in a dosedependent manner whereas 3-(4-octadecyl)-benzoylacrylic acid, arachidonyltrifluoromethylketone and bromoenol lactone have no effect [4]. Many properties of brain plasmalogen-selective PLA,
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are distinct from those of myocardial Ca2+-independent plasmalogen-selective PLA, and kidney cytosolic Ca2+-PLAz (Table 1) .
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Role of plasmalogen-selective PLA,
Plasmalogen-selective PLA, may be involved in the regulation of neural function by modulating the levels of second messengers such as arachidonate, eicosanoids, and PAF [2] . Although the precise role of this PLA, in neural function is not fully understood, there is a growing body of evidence to suggest a role in the release of arachidonic acid during long-term potentiation [ 121. Recent studies on Ca'+-independent PLA, from P388DI macrophages have indicated that this enzyme possesses CoA-independent transacylase activity [13] suggesting that this PLA, may be involved in the remodelling of phospholipids in biomembranes. Bromoenol lactone, a potent inhibitor of Ca2+-independent plasmalogen-selective PLA, from heart, blocks the incorporation of arachidonic acid in a dose-dependent manner. These studies suggest that CaZ+-independent PLA, may regulate the incorporation of arachidonic acid into phospholipids by providing the lysophospholipids for acylation reactions. It is possible that a similar process occurs in brain tissue under normal conditions. In pathological situations such as ischaemia, head injury, and AD, plasmalogen-selective PLA, may be involved in a rapid release of arachidonic acid from plasmalogens thus producing changes in membrane phospholipid composition, permeability, and fluidity [14] . These changes in membrane properties allow enhanced Ca2+-influx which can lead to an uncontrolled sustained increase in cytosolic Ca2+. The increased levels of Ca2+ may be responsible for increased lipolysis, proteolysis and disaggregation of microtubules with disruption of the cytoskeleton and membrane structure [ 151. This process along with the accumulation of reactive oxygen species (ROS) may be toxic and responsible for neurodegeneration. 
Involvement of plasmalogen-selective PLAz in AD
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reported recently in AD [18] , ischaemia , and head injury [22] . We have observed significantly lower levels of ethanolamine glycerophospholipids in plasma membranes and synaptosomal plasma membrane preparations from AD patients than in control brains [7] . In our study we did not separate diacylglycerophospholipids from plasmalogens. Ethanolamine plasmalogen was separated from the diacyl form and quantified from AD, Huntington's disease (HD), and Parkinson's disease (PD) brain tissue at post-mortem (Figure 1) . A marked decrease in ethanolamine plasmalogen content of affected pathological AD brain as compared with control and unaffected AD brains suggests the stimulation of plasmalogen-selective PLA, [6, 14] . T h e possibility of a decrease in ethanolamine plasmalogen synthesis has not been ruled out. We propose that stimulation of Ca'+-independent plasmalogen-selective PLA, produces a deficiency of ethanolamine plasmalogen in AD neural membranes and may be responsible for changes in membrane integrity, permeability, and loss of synapses. Our proposal is supported by recent findings that indicate that P-amyloid stimulates PLA, activity in a dose-dependent manner and that this increase in PLA, activity can be blocked by PLA, inhibitors [lo] . Increased activity of PLA, changes in membrane integrity together with compromised energy metabolism, accumulation of ROS and abnormal signal transduction may be associated with neurodegeneration in AD. Studies on phospholipid metabolism in the brains of patients with schizophrenia have also demonstrated a reduced phosphatidylcholine mass in neural membranes, elevated PLA, activity and abnormal phospholipid metabolism [23, 24] .
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